Abstract
Rheumatoid arthritis (RA) is often accompanied by anaemia, the severity of which correlates with the activity of the disease. This particular kind of anaemia, anaemia of chronic disease (ACD) is characterised by decreased serum iron and decreased transferrin saturation despite the presence of normal or increased bone marrow iron stores (Cartwright and Lee 1971).The reticulocyte count is low for the degree of anaemia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315–324
Baer AN, Dessypris EN, Goldwasser E, Krantz SB (1987) Blunted erythropoietin response to anemia in rheumatoid arthritis. Br J Haematol 66: 559–564
Baer AN, Dessypris EN, Krantz SB (1990) The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis. Semin Arthritis Rheum 19: 209–223
Birgegärd G, Hällgren R, Caro J (1987) Serum erythropoietin in rheumatoid arthritis and other inflammatory arthritides. Relationship to anemia and the effect of anti-inflammatory treatment. Br J Haematol 65: 479–483
Cartwright GE, Lee GR (1971) The anemia of chronic disorders. Br J Haematol 21: 147–152
Erslev A J, Wilson J, Caro J (1987) Erythropoietin titers in anemic nonuremic patients. J Lab Clin Med 109: 429–433
Maury CPJ, Andersson LC,Teppo A.M etal. (1988) Mechanism of anemia in rheumatoid arthritis: demonstration of raised interleukin-1 concentrations in anemic patients and of interleukin-1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia ( HEL) cells in vitro. Ann Rheum Dis 47: 972–978
Means RT, Olsen NJ, Krantz SB, Dessypris EN, Graber SE, Stone WJ, O’Neil VJ, Pincus T (1989) Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. Arthritis Rheum 32: 638–642
Pincus T, Olsen NJ, Russell I J, Wolfe F, Harris ER, Schnitzer TJ, Boccagno JA, Krantz SB (1990) Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 89: 161–168
Sehooley JC, Kullgren B, Allison AC (1987) Inhibition by interleukin-1 on the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anemias. Br J Haematol 67: 11–17
Takashina N, Kondo H, Kashiwazaki S (1990) Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis. J Rheumatol 17: 885–887
Tauchi T, Ohyashiki JH, Fujeda H, Lin K-Y, Ohyashiki K,Toyama K (1990) Correction of anemia in rheumatoid arthritis by recombinant human erythropoietin. Br J Haematol 29: 235–236
Thompson PW, Silman AJ, Kirwan JR, Currey HLF (1987) Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response. Arthritis Rheum 30: 618–623
Vreugdenhil G, Swaak AJG (1990) Anemia in rheumatoid arthritis: pathogenesis, diagnosis and treatment. Rheumatol Int 9: 243–257
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Pettersson, T., Rosenlöf, K., Mickos, A., Friman, C., Fyhrquist, F. (1992). Recombinant Human Erythropoietin in the Treatment of Anaemia in Rheumatoid Arthritis. In: Pagel, H., Weiss, C., Jelkmann, W. (eds) Pathophysiology and Pharmacology of Erythropoietin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77074-6_34
Download citation
DOI: https://doi.org/10.1007/978-3-642-77074-6_34
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77076-0
Online ISBN: 978-3-642-77074-6
eBook Packages: Springer Book Archive